A multi-center, uncontrolled, open-label, evaluation of lamotrigine monotherapy in adult subjects with newly diagnosed epilepsy or recurrent epilepsy (currently untreated). - Trial 2015-004878-15
Access comprehensive clinical trial information for 2015-004878-15 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline K.K. (GSK) and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-004878-15
Trial Details
EU Clinical Trials Register • 2015-004878-15
A multi-center, uncontrolled, open-label, evaluation of lamotrigine monotherapy in adult subjects with newly diagnosed epilepsy or recurrent epilepsy (currently untreated).
Study Focus
Sponsor & Location
GlaxoSmithKline K.K. (GSK)
GSK
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Please see inclusion criteria.
ICD-10 Classifications
Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus
Data Source
EU Clinical Trials Register
2015-004878-15
Non-Device Trial